NantHealth, Inc. (NASDAQ:NH) Files An 8-K Results of Operations and Financial Condition
Item 2.02
|
Results of Operations and Financial Condition.
|
release announcing its financial results for the three months
ended March 31, 2017. A copy of the press release is furnished as
Exhibit 99.1 hereto and incorporated herein by reference.
information furnished in Item 2.02 and Exhibit 99.1 of this
Current Report on Form 8-K shall not be deemed “filed” for
purposes of Section 18 of the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), or otherwise subject to the
liabilities of that section, and such information shall not be
deemed incorporated by reference in any filing under the
Securities Act of 1933, as amended, or the Exchange Act, except
as shall be expressly set forth by specific reference in such
filing.
|
Item 9.01
|
Financial Statements and Exhibits.
|
Current Report on Form 8-K:
|
Exhibit No.
|
Description
|
|
99.1
|
Press Release dated May 10, 2017 announcing results for
the quarter ended March 31, 2017. |
About NantHealth, Inc. (NASDAQ:NH)
NantHealth, Inc. is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples. The Company also offers Nant Operating System (NantOS) and NantOS applications to healthcare providers and payors, self-insured employers and biopharmaceutical companies. It offers CLINICS, an integrated solution that includes GPS Cancer, NantOS and the NantOS applications. The CLINICS solution includes System Infrastructure, Knowledge Platform, Provider Platform and Payor Platform. NantHealth, Inc. (NASDAQ:NH) Recent Trading Information
NantHealth, Inc. (NASDAQ:NH) closed its last trading session up +0.20 at 3.44 with 121,737 shares trading hands.
